AKBA vs GOOGL: Which Stock is Better?

Side-by-side comparison of Akebia Therapeutics Inc and Alphabet Inc in 2026

Comparison Updated:

AKBA

Akebia Therapeutics Inc

$1.55

GOOGL

Alphabet Inc

$336.44

Key Metrics Comparison

MetricAKBAGOOGLWinner
Market Cap$417.89MN/AAKBA
P/E RatioN/A30.77GOOGL
EPS (TTM)$N/A$10.82GOOGL
Revenue Growth0.2%0.2%AKBA
Gross Margin82.9%59.7%AKBA

Analyze AKBA

Full quant analysis

Analyze GOOGL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AKBA or GOOGL a better investment?

Comparing AKBA and GOOGL: Akebia Therapeutics Inc has a market cap of $417.89M while Alphabet Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AKBA and GOOGL?

AKBA (Akebia Therapeutics Inc) and GOOGL (Alphabet Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AKBA or GOOGL?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: AKBA or GOOGL?

AKBA has higher revenue growth at 0.2% vs 0.2% for GOOGL.

Which company is more profitable: AKBA or GOOGL?

Akebia Therapeutics Inc (AKBA) has higher gross margins at 82.9% compared to 59.7% for GOOGL.

Which is the larger company: AKBA or GOOGL?

Akebia Therapeutics Inc (AKBA) is larger with a market cap of $417.89M compared to N/A for GOOGL.

Should I buy AKBA or GOOGL in 2026?

Both AKBA and GOOGL have investment merit. AKBA trades at $1.55 while GOOGL trades at $336.44. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AKBA and GOOGL stock?

Key differences: Market Cap ($417.89M vs N/A), P/E Ratio (N/A vs 30.8x), Revenue Growth (0.2% vs 0.2%), Gross Margin (82.9% vs 59.7%).

Popular Stock Comparisons